| abstract |
The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), n n n n n n n n n n or an enantiomer thereof, or a pharmaceutically acceptable salt thereof, where R 1 , R 2 , R 3 , R 4 , R 5 , E, L, Z and n are as defined herein, to processes for preparing such compounds, to pharmaceutical compositions containing them, to the use of such inhibitors and to methods for their therapeutic use, particularly in the treatments of obesity and diabetes mellitus. |